Development and preclinical characterisation of 99mTc-labelled Affibody molecules with reduced renal uptake. (Q39966231)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18594815%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Development and preclinical characterisation of 99mTc-labelled Affibody molecules with reduced renal uptake (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18594815%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18594815%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Anna Orlova

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18594815%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

Torun Ekblad

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18594815%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Thuy Tran

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18594815%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Charles Widström

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18594815%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Joachim Feldwisch

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18594815%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Lars Abrahmsén

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18594815%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Anders Wennborg

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18594815%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Amelie Eriksson Karlström

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18594815%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

publication date

2 July 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18594815%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

number of pages

11

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18594815%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18594815%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18594815%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

2245-2255

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18594815%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00259-008-0845-7

9 January 2020

exact match

0 references

cites work

Comparison of HER-2 overexpression in primary breast cancer and metastatic sites and its effect on biological targeting therapy of metastatic disease

1 reference

12 December 2020

Development of radioimmunotherapeutic and diagnostic antibodies: an inside-out view.

1 reference

12 December 2020

Phage display selection of Affibody molecules with specific binding to the extracellular domain of the epidermal growth factor receptor.

1 reference

12 December 2020

Pre-clinical evaluation of [111In]-benzyl-DOTA-Z(HER2:342), a potential agent for imaging of HER2 expression in malignant tumors.

1 reference

12 December 2020

Imaging tumors with peptide-based radioligands.

1 reference

12 December 2020

Tumor imaging using a picomolar affinity HER2 binding affibody molecule

1 reference

12 December 2020

Molecular targeting with radionuclides: state of the science

1 reference

12 December 2020

Affibody molecules: potential for in vivo imaging of molecular targets for cancer therapy

1 reference

12 December 2020

Effects of intravenous amino acid administration with Y-90 DOTA-Phe1-Tyr3-Octreotide (SMT487[OctreoTher) treatment

1 reference

12 December 2020

Synthetic affibody molecules: a novel class of affinity ligands for molecular imaging of HER2-expressing malignant tumors

1 reference

12 December 2020

Evaluation of [(111/114m)In]CHX-A''-DTPA-ZHER2:342, an affibody ligand coniugate for targeting of HER2-expressing malignant tumors

1 reference

12 December 2020

Trastuzumab--mechanism of action and use in clinical practice

1 reference

12 December 2020

Renal uptake of radiolabeled octreotide in human subjects is efficiently inhibited by succinylated gelatin.

1 reference

12 December 2020

Chemical synthesis of triple-labelled three-helix bundle binding proteins for specific fluorescent detection of unlabelled protein.

1 reference

12 December 2020

Pharmacokinetics and biodistribution of genetically engineered antibodies

1 reference

12 December 2020

Megalin is essential for renal proximal tubule reabsorption of (111)In-DTPA-octreotide.

1 reference

12 December 2020

Engineered single chain antibody fragments for radioimmunotherapy.

1 reference

12 December 2020

Use of polyglutamic acids to reduce uptake of radiometal-labeled minigastrin in the kidneys.

1 reference

12 December 2020

Reducing the renal uptake of radiolabeled antibody fragments and peptides for diagnosis and therapy: present status, future prospects and limitations

1 reference

12 December 2020

In vivo evaluation of cysteine-based chelators for attachment of 99mTc to tumor-targeting Affibody molecules

1 reference

12 December 2020

Affibody molecules: new protein domains for molecular imaging and targeted tumor therapy

1 reference

12 December 2020

(99m)Tc-maEEE-Z(HER2:342), an Affibody molecule-based tracer for the detection of HER2 expression in malignant tumors.

1 reference

12 December 2020

99mTc-chelator engineering to improve tumour targeting properties of a HER2-specific Affibody molecule.

1 reference

12 December 2020

Imaging of HER2-expressing tumours using a synthetic Affibody molecule containing the 99mTc-chelating mercaptoacetyl-glycyl-glycyl-glycyl (MAG3) sequence.

1 reference

12 December 2020

Engineering novel binding proteins from nonimmunoglobulin domains

1 reference

12 December 2020

Cellular studies of binding, internalization and retention of a radiolabeled EGFR-binding affibody molecule

1 reference

12 December 2020

Indication for different mechanisms of kidney uptake of radiolabeled peptides.

1 reference

12 December 2020

111In-benzyl-DTPA-ZHER2:342, an affibody-based conjugate for in vivo imaging of HER2 expression in malignant tumors.

1 reference

12 December 2020

Localisation and mechanism of renal retention of radiolabelled somatostatin analogues

1 reference

12 December 2020

Efficient tumor targeting by single-domain antibody fragments of camels

1 reference

12 December 2020

Safe and effective inhibition of renal uptake of radiolabelled octreotide by a combination of lysine and arginine

1 reference

12 December 2020

10.1007/S00259-008-0845-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18594815%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference